Evidence map›Paper›PMID 35046993›Full record

ArticleFrontiers in genetics2021

Identification of Five Cytotoxicity-Related Genes Involved in the Progression of Triple-Negative Breast Cancer.

Yan Zhang, Gui-Hui Tong, Xu-Xuan Wei, Hai-Yang Chen, Tian Liang, Hong-Ping Tang, Chuan-An Wu, Guo-Ming Wen, Wei-Kang Yang, Li Liang and 1 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in genetics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Cells · 2024
    Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 1 country.

Yan ZhangDepartment of Pathology, School of Basic Medical Sciences, Southern Medical University/Nanfang Hospital, Southern Medical University, Guangzhou, China.
Gui-Hui TongDepartment of Pathology,The first Affiliated Hospital,Guangzhou Medical University, Guangzhou, China.
Xu-Xuan WeiDepartment of Pathology, The First Affiliated Hospital of Guangdong University Of Pharmacy, Guangzhou, China.
Hai-Yang ChenDepartment of Pathology, The First Affiliated Hospital of Guangdong University Of Pharmacy, Guangzhou, China.
Tian LiangDepartment of Pathology, The First Affiliated Hospital of Guangdong University Of Pharmacy, Guangzhou, China.
Hong-Ping TangDepartment of Pathology, Shenzhen Maternity & Child Healthcare Hospital, Shenzhen, China.
Chuan-An WuDepartment of Prevention and Health Care, Shenzhen Longhua District Maternity & Child Healthcare Hospital, Shenzhen, China.
Guo-Ming WenDepartment of Prevention and Health Care, Shenzhen Longhua District Maternity & Child Healthcare Hospital, Shenzhen, China.
Wei-Kang YangDepartment of Prevention and Health Care, Shenzhen Longhua District Maternity & Child Healthcare Hospital, Shenzhen, China.
Li LiangDepartment of Pathology, School of Basic Medical Sciences, Southern Medical University/Nanfang Hospital, Southern Medical University, Guangzhou, China.
Hong ShenDepartment of Pathology, School of Basic Medical Sciences, Southern Medical University/Nanfang Hospital, Southern Medical University, Guangzhou, China.
Shenzhen Maternity and Child Healthcare Hospital · CNFirst Affiliated Hospital of Guangdong Pharmaceutical University · CNSouthern Medical University · CNGuangzhou Medical University · CNNanfang Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

breast cancerCD8+ T cellDUOX2GALNTL5therapeutic efficacy

Identifiers

PMID35046993
PMCPMC8762060
OpenAlexW4206417724

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.